Berlin-based HealthTech company Recare has secured up to €37M in growth financing, including a €7M option, to further develop its AI platform and expand beyond Germany.
Berlin-based HealthTech company Recare has secured up to €37M in growth financing, including a €7M option, to further develop its AI platform and expand beyond Germany.
Munich-based Twogee Biotech has secured €2.2M in seed funding to industrialize its enzyme-based platform for converting biomass residues into sustainable, second-generation raw materials.
Berlin-based seed+speed Ventures has closed its third fund at €90 million, significantly above its original €30 million target. Led by Carsten Maschmeyer and Alexander Kölpin, the early-stage investor will focus on European B2B and enterprise software startups at pre-seed and seed stage, with a strong emphasis on applied and secure
Berlin-based early-stage investor b2venture has closed its fifth fund at the €150M hard cap, marking the firm’s largest early-stage vehicle to date. Fund V is designed to back Europe’s next generation of technology leaders building scalable, defensible products and digital business models from the earliest stages.
Co-reactive has raised €6.5M in Seed funding to scale a CO₂ mineralisation process that converts captured emissions into supplementary cementitious materials designed to reduce clinker use in cement while improving performance. The company will use the new capital to move from prototype operations toward industrial deployment.
Munich-based Arctis AI has officially launched alongside the close of a million-dollar-scale pre-seed funding round, backing its ambition to reduce administrative friction in Europe’s construction and infrastructure projects through AI-driven contract intelligence.
Exciva, a Heidelberg-based biopharmaceutical company developing therapies for neuropsychiatric conditions, has closed a €51M ($59M) Series B funding round. The financing will support clinical development of its lead programme targeting agitation in Alzheimer’s disease.
Cancilico, a Dresden-based AI diagnostics company focused on blood cancer, has raised €2.5M in seed funding to accelerate the rollout of its software platform for bone marrow analysis. The company aims to make AI-supported diagnostics a routine part of hematology workflows worldwide.
Berlin-based AI startup GeneralMind has raised €10.2M ($12M) in an equity financing round to develop its autonomous “System of Action,” an operational AI layer designed to sit on top of existing ERP systems.
Germany-based warehouse automation company NEOintralogistics has raised €3M in a seed funding round to expand its robotics-as-a-service offering and accelerate adoption of automated picking systems.
